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The components and organization of the respiratory chain in helminth mitochondria vary remarkably depending upon the stage of the life
cycle. Mitochondrial complex I in the parasitic helminth Ascaris suum uses ubiquinone-9 (UQ9) and rhodoquinone-9 (RQ9) under aerobic
and anaerobic conditions, respectively. In this study, we investigated structural features of the quinone reduction site of A. suum complex I
using a series of quinazoline-type inhibitors and also by the kinetic analysis of rhodoquinone-2 (RQ2) and ubiquinone-2 (UQ2) reduction.
Structure–activity profiles of the inhibition by quinazolines were comparable, but not completely identical, between NADH-RQ2 and
NADH-UQ2 oxidoreductase activities. However, the inhibitory mechanism of quinazolines was competitive and partially competitive against
RQ2 and UQ2, respectively. The pH profiles of both activities differed remarkably; NADH-RQ2 oxidoreductase activity showed an optimum
pH at 7.6, whereas NADH-UQ2 oxidoreductase activity showed two optima pH at 6.4 and 7.2. Our results indicate that although A. suum
complex I uses both RQ2 and UQ2 as an electron acceptor, the manner of reaction (or binding) of the two quinones differs.
D 2003 Elsevier B.V. All rights reserved.Keywords: Ascaris suum; Complex I; Rhodoquinone; Ubiquinone; Quinone reaction site1. Introduction
Parasitic helminths have exploited a variety of energy
transducing systems in their adaptation to peculiar habitats in
their hosts [1–4]. The parasitic nematode, Ascaris suum,
resides in the host small intestine where oxygen tensions are
low, and has exploited a unique anaerobic respiratory chain
to adapt to its microaerobic habitat, called the NADH-
fumarate reductase system [5–8]. The system is part of the
unique respiratory system of parasitic helminths [1–4] and is
the terminal step in the phosphoenolpyruvate carboxykinase-
succinate pathway, which is found in many anaerobic organ-
isms [9–11]. Electrons from NADH are accepted by rho-
doquinone through complex I (NADH-rhodoquinone0005-2728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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8585, Japan.oxidoreductase), and then transferred to fumarate through
complex II (rhodoquinol-fumarate reductase). The anaerobic
electron transfer in complex I couples with proton transport
across the innermitochondrial membrane, providing ATP
even in the absence of oxygen. This system has been thought
to be a good target for developing a new class of anthelmin-
tics [12].
In the previous study [12], we reported that an
anthelmintic compound, nafredin, selectively inhibits hel-
minth complex I at concentrations in the order of nano-
molar, but not rat liver mitochondrial complex I. Kinetic
analysis revealed that the inhibition by nafredin is com-
petitive against an exogenous short-chain rhodoquinone
(n-decylrhodoquinone). These findings along with the fact
that helminth complex I uses both rhodoquinone-9 (RQ9)
and ubiquinone-9 (UQ9) as an electron acceptor suggest
that the structural features of the quinone reduction site
of helminth complex I may differ from that of mamma-
lian complex I.
To probe the structural and functional characteristics of
the terminal electron transfer step of bovine complex I,
Fig. 1. Structures of quinazoline derivatives.
Table 1
Inhibition of NADH-UQ2 and NADH-RQ2 oxidoreductase activity by
quinazoline derivatives
Compound IC50 (nM)
A. suum Bovine
UQ2 RQ2 UQ2 RQ2
a
1 1.3 3.8 25 75
2 0.8 1.8 10 13
3 100 150 48 95
T. Yamashita et al. / Biochimica et Biophysica Acta 1608 (2004) 97–10398potent and specific inhibitors have been shown to be
useful tools [13–16]. Therefore, in a preliminary study,
we screened a variety of bovine complex I inhibitors for
A. suum complex I. Throughout the screening, we found
that some quinazoline-type inhibitors (Fig. 1) are very
effective against the enzyme and showed stronger inhib-
itory activity than nafredin. In this study, we character-
ized the quinone reduction site of A. suum complex I
using a series of quinazolines with rhodoquinone-2 (RQ2)
or ubiquinone-2 (UQ2) as an electron acceptor. Further-
more, we carried out detailed kinetic analyses of RQ2 and
UQ2 reduction. Our results demonstrate that the manner
of reaction (or binding) of UQ2 and RQ2 with helminth
complex I differs.4 130 480 1100 2200
5 72 300 250 1000
6 520 440 78 400
7 470 500 2900 11000
8 1.3 1.2 29 75
9 140 250 700 1000
10 600 430 1000 590
The IC50 value was defined as the molar concentration of the quinazoline
derivatives that decreased NADH-UQ2 and NADH-RQ2 oxidoreductase
activity with 50 AM UQ2 and RQ2, respectively, to 50% of the control
activity.b
a Exceptionally, NADH-RQ2 oxidoreductase activity of bovine SMP
was carried out with 30 AM RQ2, because substrate inhibition was observed
at high concentration range of RQ2.
b The values were averaged from two independent experiments.2. Materials and methods
2.1. Chemicals and A. suum
UQ2 was purchased from Sigma. RQ2 was synthesized
as described [17]. A. suum was obtained from a slaughter
house, in Shibaura, Tokyo. Muscle of adult worm with
cuticle was isolated and frozen at  80 jC. Compounds
1, 2 and 5 were synthesized as described previously [18].
The synthetic procedures of other quinazolines will be
described elsewhere.2.2. Preparation of A. suum mitochondria and complex I
assay
The preparation of A. suum mitochondria from adult
worms described previously [7] was improved as follows.
Frozen muscles with cuticles were thawed at 4 jC over-
night. After the separation of cuticles, muscles stored in 0.15
M KCl were minced with scissors. Minced muscle was
suspended with the same volume (w/v) of Chappell-Perry
buffer (50 mM Tris–HCl, pH 7.4, 0.1M KCl, 1 mM ATP, 5
mM MgSO4 and 1 mM EDTA) and broken using a waring
blender, the CELL MASTER CM-100, from Iuchi Co.
(10,000 rpm for 1 min and 18,000 rpm for 1 min). Then
the suspension was homogenized with a glass-teflon ho-
mogenizer (three strokes). After the addition of 10 volumes
(w/w) of Chappell-Perry buffer, the homogenate was centri-
fuged at 750 g for 10 min. The supernatant was centri-
fuged again at 17000 g for 10 min. The pellets were
collected and homogenized by grass-teflon homogenizer
(three strokes). The homogenate was diluted with 10 vol-
umes of Chappell-Perry buffer and centrifuged at 20000 g
for 10 min. This operation was repeated several times. After
the centrifugation, the pellets were collected as mitochon-
dria and homogenized with a glass-teflon homogenizer
(three strokes). Isolated mitochondria were frozen and
stored at  80 jC. In most of the experiments, we did not
use inside-out submitochondrial particles (SMP) because the
amount of mitochondria isolated from the muscle of A.
suum is very limited. Instead, mitochondrial preparations
were sonicated shortly before use to obtain NADH-perme-
able mitochondrial preparations. These sonicated mitochon-
dria oxidize externally added NADH.
Fig. 2. Double-reciprocal plots of the inhibition of NADH-UQ2 and NADH-RQ2 oxidoreductase activities by compound 1 with various concentrations of UQ2
(A) and RQ2 (B), respectively. NADH-UQ2 and NADH-RQ2 oxidoreductase activities of A. suum adult mitochondria were measured in 50 mM potassium
phosphate buffer, pH 7.2, containing (A) 0 nM (.), 0.3 nM (E), 0.8 nM (n) and 1.5 nM compound 1 (o); (B) 0 nM (.), 0.3 nM (E), 1 nM (n) and 4 nM
compound 1 (o).
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ductase assays, which were performed under aerobic con-
ditions previously [12], were carried out under anaerobic
condition as follows. The reason for the change in the assay
conditions is described in the Section 3. These activities
were measured spectrophotometrically by monitoring the
oxidation of NADH at 340 nm (e = 6.2 mM 1 cm 1) in a
reaction mixture (total 1 ml) containing 50 mM potassium
phosphate buffer, pH 7.2, 10 mM h-D-glucose, 20 units of
glucose oxidase, 26 units of catalase, 200 AM NADH, 10–
80 AM UQ2/RQ2 and enzyme solution. NADH-fumarate
oxidoreductase activity was measured as described [12].
2.3. Preparation of bovine heart SMP and complex I assay
Preparation of bovine heart SMP and complex I assay
were carried out as described previously [19]. However,to compare with A. suum complex I assay, bovine
complex I assay was also carried out under anaerobic
condition as follows: 10 mM h-D-glucose, 20 units of
glucose oxidase and 26 units of catalase were added to
original solution, and 2 mM KCN and 0.2 AM MOA-
stilbene were omitted.3. Results and discussion
3.1. Reactivity of A. suum mitochondrial complex I with
UQ2 and RQ2
In the NADH-UQ2 (or RQ2) oxidoreductase assay for A.
suum mitochondria, significant NADH oxidation was ob-
served under aerobic conditions irrespective of the absence of
exogenous quinone. This NADH oxidation could not be
Fig. 4. Effect of pH on the mechanism of inhibition of NADH-UQ2 oxidoreductas
mitochondria was measured in 50 mM potassium phosphate buffer, pH 6.0 (A): 0 n
nM (.), 0.5 nM (E), 1.0 nM (n) and 3.0 nM compound 1 (o); pH 7.2 (C): 0 nM (
nM (.), 0.2 nM (E), 0.4 nM (n) and 0.8 nM compound 1 (o).
Fig. 3. The pH optima of NADH-UQ2, NADH-RQ2 and NADH-fumarate
oxidoreductase activities. NADH-UQ2, NADH-RQ2 and NADH-fumarate
oxidoreductase activities of A. suum adult mitochondria were measured
with 50 AM UQ2 (.) and RQ2 (E), and 5 mM fumarate (x), respectively,
in potassium phosphate buffer, between pH 6.0 and 8.0. The values reported
represent the meansF S.D. of three independent measurements.
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antimycin A and KCN, and interferes with the accurate
measurement of NADH-UQ2 (or RQ2) oxidoreductase activ-
ity. This phenomenon is probably due to direct electron
transfer from endogenous rhodoquinol (RQ9H2) to molecular
oxygen because of the high autoxidation rate of RQ9H2 to
RQ9. In fact, we could neither prepare nor store pure RQ2H2
using typical experimental procedures. Therefore, we carried
out the assays anaerobically throughout this study as no
NADH oxidation was observed under the anaerobic condi-
tions described in the Section 2. [12]. Under these conditions,
traces of NADH oxidation by mitochondria were linear at
each concentration of UQ2 and RQ2, enabling accurate
measurement of the enzyme activity. The averaged Km and
Vmax values of NADH-UQ2 and NADH-RQ2 oxidoreductase
activities are 2.4F 0.14 and 3.1F 0.02 AM, and 164F 9 and
52F 3 nmol NADH/min/mg of proteins, respectively. Al-
though RQ2 served as an electron acceptor of complex I in
bovine SMP, substrate inhibition was observed at high
concentration range of RQ2, and the precise kinetic param-
eters could not be calculated.e activity by compound 1. NADH-UQ2 reductase activity of A. suum adult
M (.), 1.0 nM (E), 1.5 nM (n) and 3.0 nM compound 1 (o); pH 6.4 (B): 0
.), 0.3 nM (E), 0.8 nM (n) and 1.5 nM compound 1 (o); and pH 8.0 (D): 0
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Quinazoline-type inhibitors are potent inhibitors of bovine
heart mitochondrial complex I [13,18]. In a preliminary
study, we found that compound 1 (IC50 = 1.3 nM) is a very
strong inhibitor of A. suum complex I superior to nafredin
(IC50 = 10 nM), the most potent inhibitor of the enzyme
reported so far [12]. To find an even more potent inhibitor,
we tried to introduce a variety of substituents into the
quinazoline ring and obtained the derivatives shown in Fig.
1. Although 6-amino and 8-methoxy derivatives elicited
inhibition comparable to or slightly stronger than that of
compound 1, the inhibitory potency, in general, drastically
decreased even with slight structural modification. This result
means that the structure of the inhibitor is strictly recognized
by the enzyme (e.g. 8-NH2 vs. 7-NH2 and 8-MeO vs. 8-EtO).
Thus, the remarkable structural dependency of the inhibition
by quinazolines is useful to detect whether the interaction
between the inhibitors and the enzyme is affected by the
quinone used as an electron acceptor.
The structure–activity profiles for the inhibition by qui-
nazolines were compared between NADH-UQ2 and NADH-
RQ2 oxidoreductases with A. suum complex I. As is clearFig. 5. Effect of pH on the mechanism of inhibition of NADH-RQ2 oxidoreductas
mitochondria was measured in 50 mM potassium phosphate buffer, pH 6.0 (A): 0 n
nM (.), 0.7 nM (E), 2.5 nM (n) and 10 nM compound 1 (o); pH 7.2 (C): 0 nM (.
nM (.), 0.8 nM (E), 1.5 nM (n) and 3.0 nM compound 1 (o).from Table 1, the profiles were comparable, but not com-
pletely identical, indicating that the enzyme recognizes the
inhibitor in a similar way regardless of the electron acceptor.
It should be realized, however, that this result does not
necessarily mean that UQ2 and RQ2 react with complex I in
an identical manner. One cannot rule out the possibility that if
the binding sites of the quinazolines and quinones entirely
differ, the inhibitory action (or binding) of quinazolines
would not be affected by the quinones.
To better understand this point, we examined the inhibi-
tion by quinazolines with Lineweaver–Burk plots using UQ2
or RQ2 as an electron acceptor. As shown in Fig. 2, compound
1 inhibited complex I acting in a partially competitive manner
against UQ2. In contrast, compound 1 acted competitively
against RQ2. Similar results were observed for compounds 5
and 8 (data not shown). It is noteworthy that nafredin also
shows a similar pattern of inhibition when UQ2 or RQ2 is
used [12]. This finding suggests that the manner of reaction
(or site) of UQ2 and RQ2 with the enzyme somewhat differs.
We also compared the structure–activity profiles for the
inhibition by quinazolines between the two activities with
bovine complex I (Table 1). The profiles were almost com-
parable, but not completely identical. The examination one activity by compound 1. NADH-RQ2 reductase activity of A. suum adult
M (.), 4.0 nM (E), 10 nM (n) and 30 nM compound 1 (o); pH 6.4 (B): 0
), 0.3 nM (E), 1.0 nM (n) and 4.0 nM compound 1 (o); and pH 8.0 (D): 0
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was impractical because of significant substrate inhibition at
high concentration range of RQ2 as described above.
3.3. Quinone reduction site of A. suum complex I
To further characterize the quinone reduction with A.
suum complex I, both NADH-UQ2 and NADH-RQ2
oxidoreductase activities were measured at various pHs
(6.0 < pH< 8.0). As the optimum pH of glucose oxidase
and catalase, which were contained in the reaction medi-
um to keep conditions anaerobic, is about 7, we did not
examine beyond this pH range. As shown in Fig. 3, the
optimum pH of NADH-RQ2 oxidoreductase activity was
7.6, which was comparable to that of NADH-fumarate
reductase activity. Unexpectedly, NADH-UQ2 oxidoreduc-
tase showed two optima at pH 6.4 and 7.2. Such a
phenomenon has never been reported for other complex
I enzymes as far as we know. In our experiments, bovine
complex I showed optimum at pH 7.6 with UQ2 and RQ2
(data not shown). These results suggest not only that the
manner of the reaction of UQ2 and RQ2 differs with A.
suun complex I, but also that the reaction mechanism of
UQ2 varies depending upon pH. Therefore, we examined
the pH-dependency of the inhibitory action of compound
1 for NADH-UQ2 oxidoreductase activity (Fig. 4). In the
pH range examined, the inhibitory mechanism remained
partially competitive against UQ2, although mixed-type
inhibition kinetics varied with pH. Thus, the change in
the reaction mechanism of UQ2 may be negligibly small,
if there is any. The competitive inhibition by compound 1
against RQ2 for NADH-RQ2 oxidoreductase was not
affected by pH changes (Fig. 5).
The components and organization of the respiratory
chain in helminth mitochondria vary widely depending
upon the stage of the life cycle and habitat [1–4]. It is
therefore interesting to elucidate whether the subunit
composition of respiratory enzymes and reaction manner
of the quinones (UQ and RQ) change with life stage. The
present study for the first time demonstrates that manners
of reaction (or binding) of UQ2 and RQ2 with A. suum
complex I are not identical, although the structural dif-
ference between the two quinones is rather slight (i.e. 3-
MeO vs. 3-NH2). Nevertheless, we do not consider the
reaction (or binding) sites of the two quinones to be quite
different since the structure–activity relationship of the
inhibitory action of quinazolines is comparable, though
not completely identical, between NADH-UQ2 and
NADH-RQ2 oxidoreductase activities, and RQ2 and UQ2
compete and at least partially compete with quinazolines,
respectively.
It remains to be elucidated whether the molecular
architecture of A. suum complex I for quinone reduction
varies with the stage of the life cycle. In this regard, it is
of interest to note that the subunit composition of A.
suum complex II changes during the life cycle [20]. Thestudy on A. suum complex I is now under investigation in
our laboratories.Acknowledgements
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